Equities research analysts at Alliance Global Partners lifted their Q3 2025 earnings per share estimates for shares of Cresco ...
After the FDA lifted the clinical hold on vTv Therapeutics ’ CATT1 trial, the firm called it a “de-risking” event for shares of the company. Alliance Global noted that the c ...
Alliance Global Partners’ price target indicates ... and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker’s Products, and Creative ...
In a report released today, Aaron Grey from Alliance Global Partners maintained a Hold rating on Sadot Group (SDOT – Research Report). The company’s shares closed today at $3.24. Easily ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results